ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Vincerx Pharma Inc (EM)

Vincerx Pharma Inc (EM) (VINC)

0.0131
0.00
(0.00%)
終了 6月14日 5:00AM

Vincerx Pharma Inc (EM) (VINC) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.0131
( - )
買値
0.00
売値
0.00
出来高
241
0.0131 日の範囲 0.0131
0.0002 52 週間の範囲 0.074
時価総額
前日終値
0.0131
始値
0.0131
最終取引時間
財務取引量
US$ 3
VWAP
0.0131
平均取引量 (3 か月)
US$ 5,275
発行済株式数
5,234,277
配当利回り
PER
-0
1 株当たり利益 (EPS)
-8.98
歳入
-
純利益
-22.65M

Vincerx Pharma Inc (EM) について

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technol... Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States. Its VersAptx bioconjugation platform combines different targeting, linker, and payload technologies to develop antibody-drug conjugates (ADC) and small molecule drug conjugates (SMDC); and provides CellTrapper technology for use in reduction of payload cellular permeability. The company develops VIP943, an antibody drug conjugate in Phase 1 dose-escalation study for relapsed/refractory acute myeloid leukemia, higher-risk MDS, and B-cell acute lymphoblastic leukemia; VIP236, an SMDC, which is in Phase 1 dose-escalation study for the treatment of patients with advanced or metastatic solid tumors; and VIP924, an anti-CXCR5 ADC that leverages the same effector chemistry in preclinical studies for b-cell malignancies. It has a collaboration with the National Institutes of Health for the Phase 1 dose-escalation of enitociclib, a highly selective cyclin-dependent kinase 9 inhibitor. The company was formerly known as Vincera Pharma, Inc. and changed its name to Vincerx Pharma, Inc. in January 2021. Vincerx Pharma, Inc. was founded in 2019 and is headquartered in San Mateo, California. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
San Mateo, United States
設立
2026
Vincerx Pharma Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker VINC. The last closing price for Vincerx Pharma (EM) was US$0.01. Over the last year, Vincerx Pharma (EM) shares have traded in a share price range of US$ 0.0002 to US$ 0.074.

Vincerx Pharma (EM) currently has 5,234,277 shares in issue. The market capitalisation of Vincerx Pharma (EM) is US$68,569.03 . Vincerx Pharma (EM) has a price to earnings ratio (PE ratio) of -0.00.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.0031310.010.0150.0163060.01304748CS
40.00043.149606299210.01270.0150.0142050.01286547CS
120.00010.7692307692310.0130.0170.0155620.01281808CS
260.0018.264462809920.01210.024450.0151930.01267102CS
52-0.0364-73.53535353540.04950.0740.0002425240.04163335CS
156-0.0481-78.59477124180.06120.10.0002527210.04655665CS
260-0.0481-78.59477124180.06120.10.0002527210.04655665CS

VINC - Frequently Asked Questions (FAQ)

What is the current Vincerx Pharma Inc (EM) share price?
The current share price of Vincerx Pharma Inc (EM) is US$ 0.0131
How many Vincerx Pharma Inc (EM) shares are in issue?
Vincerx Pharma Inc (EM) has 5,234,277 shares in issue
What is the market cap of Vincerx Pharma Inc (EM)?
The market capitalisation of Vincerx Pharma Inc (EM) is USD 68.57k
What is the 1 year trading range for Vincerx Pharma Inc (EM) share price?
Vincerx Pharma Inc (EM) has traded in the range of US$ 0.0002 to US$ 0.074 during the past year
What is the PE ratio of Vincerx Pharma Inc (EM)?
The price to earnings ratio of Vincerx Pharma Inc (EM) is -0
What is the registered address of Vincerx Pharma Inc (EM)?
The registered address for Vincerx Pharma Inc (EM) is 1825 S. Grant Street, San Mateo, California, 94402
What is the Vincerx Pharma Inc (EM) website address?
The website address for Vincerx Pharma Inc (EM) is vincerx.com
Which industry sector does Vincerx Pharma Inc (EM) operate in?
Vincerx Pharma Inc (EM) operates in the Biotechnology & Life Sciences sector

VINC 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

VINC Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock